Anteris Technologies Global Corp. (AVR)
NASDAQ: AVR · Real-Time Price · USD
7.56
-0.01 (-0.13%)
May 19, 2026, 11:31 AM EDT - Market open
Anteris Technologies Global Employees
Anteris Technologies Global had 174 employees as of December 31, 2025. The number of employees increased by 38 or 27.94% compared to the previous year.
Employees
174
Change (1Y)
38
Growth (1Y)
27.94%
Revenue / Employee
$10,638
Profits / Employee
-$547,724
Market Cap
724.10M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 174 | 38 | 27.94% |
| Dec 31, 2024 | 136 | 15 | 12.40% |
| Sep 30, 2024 | 138 | - | - |
| Mar 31, 2024 | 121 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| DENTSPLY SIRONA | 14,000 |
| Azenta | 2,900 |
| AtriCure | 1,350 |
| STAAR Surgical Company | 921 |
| AngioDynamics | 675 |
| OraSure Technologies | 500 |
| Kestra Medical Technologies | 330 |
| Alamar Biosciences | 222 |
AVR News
- 4 days ago - Anteris Technologies price target raised to $18 from $17 at Barclays - TheFly
- 6 days ago - Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors - GlobeNewsWire
- 6 days ago - How Should Investors Value Anteris Technologies Global Corp (AVR) After Q1 2026? EPS Not ... - GuruFocus
- 6 days ago - Anteris Announces Results for the First Quarter of 2026 - GlobeNewsWire
- 10 days ago - Sio Capital Management, LLC's Strategic Acquisition in Anteris Technologies Global Corp - GuruFocus
- 14 days ago - Anteris Technologies: First U.S. patients treated in global PARADIGM trial - TheFly
- 14 days ago - Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial - GlobeNewsWire
- 21 days ago - Anteris Technologies (AVR) Achieves Medicare Reimbursement for PARADIGM Trial - GuruFocus